Skip to main content

You make this possible. Support our independent, nonprofit newsroom today.

Give Now

Seattle Researchers Engineer HIV-Resistant T Cell

Ross Reynolds speaks with Dr. David Rawlings, director of the Center for Immunity and Immunotherapies at Seattle Children's Research Institute, about how his team pioneered a breakthrough gene-editing technique that could help patients with HIV, genetic blood diseases and certain cancers. Their study was published in the September issue of Science Translational Medicine.

Why you can trust KUOW